Companies / Purple Biotech Ltd.
Purple Biotech Ltd.
Nasdaq: PPBTForeign · IFRSCIK 1614744REHOVOT
Financials
Ownership
1.86B shares outstanding
Ownership
| Institutions | <0.01% | 2,685 |
| Public float | 100.00% | 1,858,909,116 |
% of common shares outstanding (single-class filing figure). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 4
View all →| Insider | % of shares | Shares |
|---|---|---|
Efron GilCEOChief Executive Officer | — | — |
Gagnon Robert E.Director | — | — |
Lankry Shai SOfficer · Director | — | — |
Schickler MichaelHead of Clinical & Reg Affairs | — | — |
Institutional holders 4
View all →| Holder | Value | % of shares |
|---|---|---|
| $7.9K | <0.01% | |
| $2.9K | <0.01% | |
| $32 | <0.01% | |
| $0 | <0.01% |
Activity
InsidersInstitutions
What insiders are doing in this stock (Form 4).No activity matches these filters.
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| Capital Ventures International | Passive13G | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| PPBT | ADR | 74638P307 |